Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.37% | 16.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.37% | 16.72% | |||
| Cost of Revenue | 40.14% | -22.13% | |||
| Gross Profit | -120.06% | 53.34% | |||
| SG&A Expenses | 53.79% | -8.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.59% | -17.35% | |||
| Operating Income | -75.86% | 30.86% | |||
| Income Before Tax | -45.65% | 13.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -45.65% | 13.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.65% | 13.97% | |||
| EBIT | -75.86% | 30.86% | |||
| EBITDA | -76.19% | 30.94% | |||
| EPS Basic | -45.39% | 14.06% | |||
| Normalized Basic EPS | -84.10% | 32.13% | |||
| EPS Diluted | -45.39% | 14.06% | |||
| Normalized Diluted EPS | -84.10% | 32.13% | |||
| Average Basic Shares Outstanding | 0.17% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||